RESOLUTION 
Expressing support for designation of March 3, 2022, as 
‘‘National Triple-Negative Breast Cancer Day’’. 
Whereas triple-negative breast cancer was recognized as a 
distinct type of cancer in 2006; 
Whereas triple-negative breast cancer disproportionately af-
fects young women, Black and Hispanic women, and 
those with BRCA gene mutations; 
Whereas triple-negative breast cancers are estrogen receptor- 
negative, progesterone receptor-negative, and HER2-neg-
ative, making them distinct from other breast cancers; 
Whereas there is no targeted therapy for triple-negative 
breast cancers; 
Whereas 10 to 20 percent of all breast cancer diagnoses are 
designated as triple-negative; 
00:58 Mar 01, 2022
HR954
2 
•HRES 954 IH 
Whereas triple-negative breast cancer can be more aggressive 
and more likely to spread and recur; 
Whereas triple-negative breast cancer accounts for around 25 
percent of all deaths from breast cancer in the United 
States; and 
Whereas March 3, 2022, would be an appropriate date to 
designate as ‘‘National Triple-Negative Breast Cancer 
Day’’: Now, therefore, be it 
Resolved, That the House of Representatives supports 
1
the designation of ‘‘National Triple-Negative Breast Can-
2
cer Day’’ to create awareness of the devastating effect of 
3
these cancers on families in the United States and the 
4
need for strong action to eradicate triple-negative breast 
5
cancer. 
6
Æ 
00:58 Mar 01, 2022
HR954
